LONDON — In saying his plan to decrease prescription drug costs, President Trump argued that each People and drug firms may gain advantage. Essential to creating this occur, he stated, could be getting Europeans — whom he forged as freeloaders within the international pharmaceutical system — to pay extra for his or her medicines.
It will not be really easy.
In outlining his “most-favored nation” proposal to tie U.S. drug costs to these paid by different developed international locations, Trump highlighted discrepancies between prices stateside versus these in Europe, a long-running incontrovertible fact that Trump framed as an injustice. Not, he and different administration officers stated, would the U.S. subsidize drugmakers’ analysis tasks that resulted in medicines that benefited the entire world.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
